-
Published 7/17/2025
Hamblen JL, Merrick C, Marx BP, Bovin MJ. Acceptability and feasibility of the clinician-administered PTSD Scale for DSM-5 training simulator. Psychol Trauma. 2025 Jul 17. PMID: 40674018.
-
Published 6/27/2025
Hahn CK, Salim SR, Tilstra-Ferrell EL, Brady KT, Marx BP, Rothbaum BO, Saladin ME, Guille C, Gilmore AK, Back SE. Written Exposure Therapy for PTSD Integrated with Cognitive Behavioral Coping Skills for Cannabis Use Disorder After Recent Sexual Assault: A Case Series. Behav Sci (Basel). 2025 Jun 27; 15(7). PMID: 40723661.
-
Published 6/23/2025
Mandavia AD, Fonda JR, Banducci AN, Ameral VE, Sistad Hall RE, Loeffel LB, Roth CE, Simpson TL, Stein MD, Marx BP, Hyde J, Davenport M, Meng F, Livingston NA. Sex and race-ethnicity influences on opioid overdose deaths among veterans diagnosed with opioid use disorder between 2016 and 2021. Drug Alcohol Depend. 2025 Sep 01; 274:112764. PMID: 40578052.
-
Published 6/9/2025
Crowe ML, Livingston NA, Keane TM, Marx BP. Measurement invariance of the PTSD checklist for the DSM-5 (PCL-5) in a veteran sample. Psychol Assess. 2025 Sep; 37(9):454-460. PMID: 40489149.
-
Published 6/9/2025
Kearns JC, Polizzi CP, Naganuma-Carreras J, Bourassa KJ, Halverson TF, Perskaudas R, Kimbrel NA, Interian A, Bossarte RM, DeBeer BB, Constans JI, Dichter ME, Dobscha SK, Goodman M, Ilgen M, Owen RR, Marx BP. A scoping review of psychosocial suicide prevention interventions among adults: Clinical trial factors, predictors, mediators, and moderators in randomized controlled trials. Clin Psychol Rev. 2025 Aug; 120:102614. PMID: 40517570.